MACARBOMYCIN, AN INHIBITOR OF PEPTIDOGLYCAN SYNTHESIS

Abstract

Macarbomycin, a new antibiotic active against gram-positive bacteria, was shown to inhibit the synthesis of peptidoglycan both in vivo and in vitro. The detailed mechanism of action is discussed.